About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Ashland Purchases Manufacturing Rights for VitalET and TPM
June 20, 2019
August 28, 2019
Click here to read more
Post navigation
Previous Post
Change of Company Name and ASX Code
Next Post
Avecho investor update – webinar recording
Related Posts
Phosphagenics Notice of Annual General Meeting
April 28, 2017
First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
May 16, 2024
Chairman Resignation
May 12, 2015